3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1/2
1
Status
Recruiting
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
42
Breast
7
Genitourinary
6
Gastrointestinal
6
Thoracic
4
Classical hematology
3
Other
2
Lymphoid
2
Head & Neck
2
Dermatologic
2
Plasma cell
1
Other neoplasm
1
Other hematologic neoplasm
1
NET
1
Endocrine
1
Conditions
Melanoma
2653
Lymphoma, T-Cell, Cutaneous
479
Skin Neoplasms
408
Carcinoma, Non-Small-Cell Lung
377
Mycosis Fungoides
330
Neoplasms
319
Keratosis, Actinic
300
Sezary Syndrome
294
Breast Neoplasms
285
Neoplasm Metastasis
284
Carcinoma, Renal Cell
280
Lymphoma, Non-Hodgkin
276
Lymphoma
264
Carcinoma, Basal Cell
263
Lymphoma, Large B-Cell, Diffuse
261
Leukemia, Lymphocytic, Chronic, B-Cell
261
Lymphoma, Follicular
259
Hodgkin Disease
247
Lymphoma, Mantle-Cell
245
Lymphoma, B-Cell, Marginal Zone
245
Precursor Cell Lymphoblastic Leukemia-Lymphoma
243
Uveal Melanoma
234
Burkitt Lymphoma
233
Lymphoma, Large-Cell, Immunoblastic
223
Colorectal Neoplasms
196
Lymphoma, Large-Cell, Anaplastic
190
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
186
Ovarian Neoplasms
181
Squamous Cell Carcinoma of Head and Neck
180
Lung Neoplasms
179
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Genital Neoplasms, Female
×
Dermatologic
×
Clear all
NCT05053230
2025-10-09
IMPROVE
Memorial Sloan Kettering Cancer Center
Phase NA
Recruiting
480 enrolled
NCT05592626
2025-07-09
START-001
Marengo Therapeutics, Inc.
Phase 1/2
Recruiting
365 enrolled